Search research articles
Contact Us
Filters
Showing results (21-30 of 88) with videos related to
Page
of 9
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 19, 2008
Clinical significance of MYCN amplification and ploidy in favorable-stage neuroblastoma: a report from the Children's Oncology Group
Jennifer Schneiderman, Wendy B London, Garrett M Brodeur, et al.
International Journal of Nanomedicine
|
September 28, 2020
Nanomicellar Lenalidomide-Fenretinide Combination Suppresses Tumor Growth in an <i>MYCN</i> Amplified Neuroblastoma Tumor
Isabella Orienti, Giovanna Farruggia, Ferro Nguyen, et al.
Drug Design, Development and Therapy
|
January 8, 2020
A Novel Nanomicellar Combination of Fenretinide and Lenalidomide Shows Marked Antitumor Activity in a Neuroblastoma Xenograft Model
Isabella Orienti, Ferro Nguyen, Peng Guan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 6, 2025
Pediatric Cancer Predisposition and Surveillance Update: Summary Perspective and Future Directions
Garrett M Brodeur, Lisa R Diller, Kim E Nichols, et al.
Molecular Cancer Therapeutics
|
December 25, 2019
Mechanisms of Entrectinib Resistance in a Neuroblastoma Xenograft Model
Suzanne P MacFarland, Koumudi Naraparaju, Radhika Iyer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 9, 2018
Enhanced Intratumoral Delivery of SN38 as a Tocopherol Oxyacetate Prodrug Using Nanoparticles in a Neuroblastoma Xenograft Model
Ferro Nguyen, Ivan Alferiev, Peng Guan, et al.
Cancer Letters
|
March 23, 2011
The effect of P75 on Trk receptors in neuroblastomas
Ruth Ho, Jane E Minturn, Anisha M Simpson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 2, 2012
Mechanisms of CHD5 Inactivation in neuroblastomas
Hiroshi Koyama, Tiangang Zhuang, Jennifer E Light, et al.
Pediatric Blood & Cancer
|
January 17, 2026
Pediatric Malignancy in the Setting of Lynch Syndrome: A Case Series and Review of the Literature
Jordan Heiman, Julia Meade, Kristin Zelley, et al.
Molecular Cancer Research : MCR
|
May 29, 2008
A functional screen identifies miR-34a as a candidate neuroblastoma tumor suppressor gene
Kristina A Cole, Edward F Attiyeh, Yael P Mosse, et al.
Page
of 9
Search research articles
Search
Showing results (21-30 of 88) with videos related to
Sort By:
Page
of 9
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 19, 2008
Clinical significance of MYCN amplification and ploidy in favorable-stage neuroblastoma: a report from the Children's Oncology Group
Jennifer Schneiderman, Wendy B London, Garrett M Brodeur, et al.
International Journal of Nanomedicine
|
September 28, 2020
Nanomicellar Lenalidomide-Fenretinide Combination Suppresses Tumor Growth in an <i>MYCN</i> Amplified Neuroblastoma Tumor
Isabella Orienti, Giovanna Farruggia, Ferro Nguyen, et al.
Drug Design, Development and Therapy
|
January 8, 2020
A Novel Nanomicellar Combination of Fenretinide and Lenalidomide Shows Marked Antitumor Activity in a Neuroblastoma Xenograft Model
Isabella Orienti, Ferro Nguyen, Peng Guan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 6, 2025
Pediatric Cancer Predisposition and Surveillance Update: Summary Perspective and Future Directions
Garrett M Brodeur, Lisa R Diller, Kim E Nichols, et al.
Molecular Cancer Therapeutics
|
December 25, 2019
Mechanisms of Entrectinib Resistance in a Neuroblastoma Xenograft Model
Suzanne P MacFarland, Koumudi Naraparaju, Radhika Iyer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 9, 2018
Enhanced Intratumoral Delivery of SN38 as a Tocopherol Oxyacetate Prodrug Using Nanoparticles in a Neuroblastoma Xenograft Model
Ferro Nguyen, Ivan Alferiev, Peng Guan, et al.
Cancer Letters
|
March 23, 2011
The effect of P75 on Trk receptors in neuroblastomas
Ruth Ho, Jane E Minturn, Anisha M Simpson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 2, 2012
Mechanisms of CHD5 Inactivation in neuroblastomas
Hiroshi Koyama, Tiangang Zhuang, Jennifer E Light, et al.
Pediatric Blood & Cancer
|
January 17, 2026
Pediatric Malignancy in the Setting of Lynch Syndrome: A Case Series and Review of the Literature
Jordan Heiman, Julia Meade, Kristin Zelley, et al.
Molecular Cancer Research : MCR
|
May 29, 2008
A functional screen identifies miR-34a as a candidate neuroblastoma tumor suppressor gene
Kristina A Cole, Edward F Attiyeh, Yael P Mosse, et al.
Page
of 9